Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | EVP | May 01, 2017 | May 04, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date May 01, 2017 · Filed May 04, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 102,516 |
Reported balance
After 2017-05-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-05-01 · Grant · Acquired 3,444 · Balance 102,516 F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively. F2: These shares include the following RSUs granted under the Company's equity plans: 1,601 RSUs which vest on 1/31/2018; 2,464 RSUs which vest in one installment of 1,213 on 1/30/2018 and one installment of 1,251 on 1/30/2019; 3,581 RSUs which vest in installments of 1,181 on 5/3/2018, 1,182 on 5/3/2019 and 1,218 on 5/3/2020; and 3,444 RSUs which vest in installments of 1,136 on 5/1/2019, 1,137 on 5/1/2020 and 1,171 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3: These shares include 344 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $162.60 · Expires 2027-05-01 | Direct | 30,501 |
Reported balance
After 2017-05-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-05-01 · Grant · Acquired 30,501 · Balance 30,501 F4: This non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively.
F2: These shares include the following RSUs granted under the Company's equity plans: 1,601 RSUs which vest on 1/31/2018; 2,464 RSUs which vest in one installment of 1,213 on 1/30/2018 and one installment of 1,251 on 1/30/2019; 3,581 RSUs which vest in installments of 1,181 on 5/3/2018, 1,182 on 5/3/2019 and 1,218 on 5/3/2020; and 3,444 RSUs which vest in installments of 1,136 on 5/1/2019, 1,137 on 5/1/2020 and 1,171 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F3: These shares include 344 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F4: This non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2017 Filed May 4, 2017 00:53 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 30,501 | $0.00 Strike: $162.60 | $0.00 |
DisclosureSEC source: 0001127602-17-016754 · form4.xml · derivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,501 Underlying: Common Stock · 30,501 shares Expires 2027-05-01 F4 · derivative.exercise_date: This non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively. Read SEC document |
| May 01, 2017 Filed May 4, 2017 00:53 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 3,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-016754 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,516 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 1,601 RSUs which vest on 1/31/2018; 2,464 RSUs which vest in one installment of 1,213 on 1/30/2018 and one installment of 1,251 on 1/30/2019; 3,581 RSUs which vest in installments of 1,181 on 5/3/2018, 1,182 on 5/3/2019 and 1,218 on 5/3/2020; and 3,444 RSUs which vest in installments of 1,136 on 5/1/2019, 1,137 on 5/1/2020 and 1,171 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 344 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 24, 2017 Filed Mar 28, 2017 22:57 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 11,219 | $166.04 | $1,862,802.76 |
DisclosureSEC source: 0001127602-17-013096 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,072 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,601 RSUs which vest on 1/31/2018; 2,464 RSUs which vest in one installment of 1,213 on 1/30/2018 and one installment of 1,251 on 1/30/2019; and 3,581 RSUs which vest in installments of 1,181 on 5/3/2018, 1,182 on 5/3/2019 and 1,218 on 5/3/2020. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 344 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 07, 2017 Filed Mar 9, 2017 22:11 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 21,553 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-011099 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,102 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,601 RSUs which vest on 1/31/2018; 2,464 RSUs which vest in one installment of 1,213 on 1/30/2018 and one installment of 1,251 on 1/30/2019; and 3,581 RSUs which vest in installments of 1,181 on 5/3/2018, 1,182 on 5/3/2019 and 1,218 on 5/3/2020. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 294 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 23:47 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 585 | $154.43 | $90,341.55 |
DisclosureSEC source: 0001127602-17-003732 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,549 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,601 RSUs which vest on 1/31/2018; 2,464 RSUs which vest in one installment of 1,213 on 1/30/2018 and one installment of 1,251 on 1/30/2019; and 3,581 RSUs which vest in installments of 1,181 on 5/3/2018, 1,182 on 5/3/2019 and 1,218 on 5/3/2020. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 294 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 01:37 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 449 | $157.16 | $70,564.84 |
DisclosureSEC source: 0001127602-17-003234 · form4.xml · nonDerivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,134 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,154 RSUs which vest in one installment of 1,553 on 1/31/2017 and one installment of 1,601 on 1/31/2018; 2,464 RSUs which vest in one installment of 1,213 on 1/30/2018 and one installment of 1,251 on 1/30/2019; and 3,581 RSUs which vest in installments of 1,181 on 5/3/2018, 1,182 on 5/3/2019 and 1,218 on 5/3/2020. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 396 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 28, 2017 Filed Feb 1, 2017 01:37 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 582 | $157.16 | $91,467.12 |
DisclosureSEC source: 0001127602-17-003234 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,583 Read SEC document |
| October 25, 2016 Filed Oct 27, 2016 00:56 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,109 | $158.76 | $334,824.84 |
DisclosureSEC source: 0001127602-16-065315 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,078 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,510 RSUs which vest on 1/28/2017; 3,154 RSUs which vest in one installment of 1,553 on 1/31/2017 and one installment of 1,601 on 1/31/2018; 3,677 RSUs which vest in two equal installments of 1,213 on 1/30/2017 and 1/30/2018 and one installment of 1,251 on 1/30/2019; and 3,581 RSUs which vest in installments of 1,181 on 5/3/2018, 1,182 on 5/3/2019 and 1,218 on 5/3/2020. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 496 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 03, 2016 Filed May 6, 2016 00:32 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 30,490 | $0.00 Strike: $156.35 | $0.00 |
DisclosureSEC source: 0001127602-16-051292 · form4.xml · derivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,490 Underlying: Common Stock · 30,490 shares Expires 2026-05-03 F4 · derivative.exercise_date: This non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/3/2018, 5/3/2019 and 5/3/2020, respectively. Read SEC document |
| May 03, 2016 Filed May 6, 2016 00:32 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 3,581 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-051292 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,989 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/3/2018, 5/3/2019 and 5/3/2020, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 1,510 RSUs which vest on 1/28/2017; 3,800 RSUs which vest in one installment on 10/25/2016; 3,154 RSUs which vest in one installment of 1,553 on 1/31/2017 and one installment of 1,601 on 1/31/2018; 3,677 RSUs which vest in two equal installments of 1,213 on 1/30/2017 and 1/30/2018 and one installment of 1,251 on 1/30/2019; and 3,581 RSUs which vest in installments of 1,181 on 5/3/2018, 1,182 on 5/3/2019 and 1,218 on 5/3/2020. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 538 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 27, 2016 Filed Apr 29, 2016 23:47 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 818 | $162.85 | $133,211.30 |
DisclosureSEC source: 0001127602-16-050338 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,408 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,510 RSUs which vest on 1/28/2017; 3,800 RSUs which vest in one installment on 10/25/2016; 3,154 RSUs which vest in one installment of 1,553 on 1/31/2017 and one installment of 1,601 on 1/31/2018; and 3,677 RSUs which vest in two equal installments of 1,213 on 1/30/2017 and 1/30/2018 and one installment of 1,251 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 538 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 25, 2016 Filed Mar 29, 2016 21:17 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 14,016 | $149.24 | $2,091,747.84 |
DisclosureSEC source: 0001127602-16-047734 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,226 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,519 RSUs which vest on 4/27/2016; 1,510 RSUs which vest on 1/28/2017, respectively; 3,800 RSUs which vest in one installment on 10/25/2016; 3,154 RSUs which vest in one installment of 1,553 on 1/31/2017 and one installment of 1,601 on 1/31/2018; and 3,677 RSUs which vest in two equal installments of 1,213 on 1/30/2017 and 1/30/2018 and one installment of 1,251 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 659 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 02, 2016 Filed Mar 4, 2016 23:16 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 26,877 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-045130 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,959 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,519 RSUs which vest on 4/27/2016; 2,975 RSUs which vest in two installments of 1,465 and 1,510 on 1/28/2016 and 1/28/2017, respectively; 3,800 RSUs which vest in one installment on 10/25/2016; 4,707 RSUs which vest in two equal installments of 1,553 on 1/31/2016 and 1/31/2017 and one installment of 1,601 on 1/31/2018; and 3,677 RSUs which vest in two equal installments of 1,213 on 1/30/2017 and 1/30/2018 and one installment of 1,251 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 562 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 31, 2016 Filed Feb 2, 2016 01:32 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 570 | $152.73 | $87,056.10 |
DisclosureSEC source: 0001127602-16-038853 · form4.xml · nonDerivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,082 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,519 RSUs which vest on 4/27/2016; 1,510 RSUs which vest on 1/28/2017; 3,800 RSUs which vest in one installment on 10/25/2016; 3,154 RSUs which vest in one installment of 1,553 on 1/31/2017 and one installment of 1,601 on 1/31/2018; and 3,677 RSUs which vest in two equal installments of 1,213 on 1/30/2017 and 1/30/2018 and one installment of 1,251 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 562 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 28, 2016 Filed Feb 2, 2016 01:32 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 551 | $150.47 | $82,908.97 |
DisclosureSEC source: 0001127602-16-038853 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,567 Read SEC document |
| October 25, 2015 Filed Oct 27, 2015 22:11 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,999 | $155.75 | $311,344.25 |
DisclosureSEC source: 0001127602-15-029627 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,118 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,519 RSUs which vest on 4/27/2016; 2,975 RSUs which vest in two installments of 1,465 and 1,510 on 1/28/2016 and 1/28/2017, respectively; 3,800 RSUs which vest in one installment on 10/25/2016; 4,707 RSUs which vest in two equal installments of 1,553 on 1/31/2016 and 1/31/2017 and one installment of 1,601 on 1/31/2018; and 3,677 RSUs which vest in two equal installments of 1,213 on 1/30/2017 and 1/30/2018 and one installment of 1,251 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 621 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 27, 2015 Filed Apr 29, 2015 00:03 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 777 | $167.91 | $130,466.07 |
DisclosureSEC source: 0001127602-15-015476 · form4.xml · nonDerivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,904 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,519 RSUs which vest on 4/27/2016; 2,975 RSUs which vest in two installments of 1,465 and 1,510 on 1/28/2016 and 1/28/2017, respectively; 7,488 RSUs which vest in one installment of 3,688 on 10/25/2015 and one installment of 3,800 on 10/25/2016; 4,707 RSUs which vest in two equal installments of 1,553 on 1/31/2016 and 1/31/2017 and one installment of 1,601 on 1/31/2018; and 3,677 RSUs which vest in two equal installments of 1,213 on 1/30/2017 and 1/30/2018 and one installment of 1,251 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 548 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 25, 2015 Filed Apr 29, 2015 00:03 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,271 | $167.91 | $213,413.61 |
DisclosureSEC source: 0001127602-15-015476 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,681 Read SEC document |
| March 27, 2015 Filed Mar 31, 2015 22:54 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 14,517 | $160.55 | $2,330,704.35 |
DisclosureSEC source: 0001127602-15-012983 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,952 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,550 RSUs which vest in one installment of 2,550 on 4/25/2015; 2,993 RSUs which vest in two annual installments of 1,474 and 1,519 on 4/27/2015 and 4/27/2016, respectively; 2,975 RSUs which vest in two installments of 1,465 and 1,510 on 1/28/2016 and 1/28/2017, respectively; 7,488 RSUs which vest in one installment of 3,688 on 10/25/2015 and one installment of 3,800 on 10/25/2016; 4,707 RSUs which vest in two equal installments of 1,553 on 1/31/2016 and 1/31/2017 and one installment of 1,601 on 1/31/2018; and 3,677 RSUs which vest in two equal installments of 1,213 on 1/30/2017 and 1/30/2018 and one installment of 1,251 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 631 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 04, 2015 Filed Mar 7, 2015 02:06 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 28,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-010546 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,214 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,550 RSUs which vest in one installment of 2,550 on 4/25/2015; 2,993 RSUs which vest in two annual installments of 1,474 and 1,519 on 4/27/2015 and 4/27/2016, respectively; 2,975 RSUs which vest in two installments of 1,465 and 1,510 on 1/28/2016 and 1/28/2017, respectively; 7,488 RSUs which vest in one installment of 3,688 on 10/25/2015 and one installment of 3,800 on 10/25/2016; 4,707 RSUs which vest in two equal installments of 1,553 on 1/31/2016 and 1/31/2017 and one installment of 1,601 on 1/31/2018; and 3,677 RSUs which vest in two equal installments of 1,213 on 1/30/2017 and 1/30/2018 and one installment of 1,251 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 519 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 30, 2015 Filed Feb 4, 2015 00:05 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 3,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-004138 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,045 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/30/2017, 1/30/2018 and 1/30/2019, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 2,550 RSUs which vest in one installment of 2,550 on 4/25/2015; 2,993 RSUs which vest in two annual installments of 1,474 and 1,519 on 4/27/2015 and 4/27/2016, respectively; 2,975 RSUs which vest in two installments of 1,465 and 1,510 on 1/28/2016 and 1/28/2017, respectively; 7,488 RSUs which vest in one installment of 3,688 on 10/25/2015 and one installment of 3,800 on 10/25/2016; 4,707 RSUs which vest in two equal installments of 1,553 on 1/31/2016 and 1/31/2017 and one installment of 1,601 on 1/31/2018; and 3,677 RSUs which vest in two equal installments of 1,213 on 1/30/2017 and 1/30/2018 and one installment of 1,251 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 519 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 28, 2015 Filed Jan 30, 2015 22:03 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 20 | $158.89 | $3,177.80 |
DisclosureSEC source: 0001127602-15-003490 · form4.xml · nonDerivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,368 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,550 RSUs which vest in one installment of 2,550 on 4/25/2015; 2,993 RSUs which vest in two annual installments of 1,474 and 1,519 on 4/27/2015 and 4/27/2016, respectively; 2,975 RSUs which vest in two installments of 1,465 and 1,510 on 1/28/2016 and 1/28/2017, respectively; 7,488 RSUs which vest in one installment of 3,688 on 10/25/2015 and one installment of 3,800 on 10/25/2016; and 4,707 RSUs which vest in two equal installments of 1,553 on 1/31/2016 and 1/31/2017 and one installment of 1,601 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 519 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 28, 2015 Filed Jan 30, 2015 22:03 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 518 | $158.89 | $82,305.02 |
DisclosureSEC source: 0001127602-15-003490 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,388 Read SEC document |
| December 31, 2014 Filed Jan 5, 2015 21:31 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 11,522 | $160.63 | $1,850,778.86 |
DisclosureSEC source: 0001127602-15-000683 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,906 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,550 RSUs which vest in one installment of 2,550 on 4/25/2015; 2,993 RSUs which vest in two annual installments of 1,474 and 1,519 on 4/27/2015 and 4/27/2016, respectively; 4,439 RSUs which vest in three installments of 1,464, 1,465 and 1,510 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; 7,488 RSUs which vest in one installment of 3,688 on 10/25/2015 and one installment of 3,800 on 10/25/2016; and 4,707 RSUs which vest in two equal installments of 1,553 on 1/31/2016 and 1/31/2017 and one installment of 1,601 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 572 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| October 25, 2014 Filed Oct 28, 2014 20:09 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 37 | $147.26 | $5,448.62 |
DisclosureSEC source: 0001127602-14-030380 · form4.xml · nonDerivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,356 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 22,081 RSUs which fully vest on 12/31/2014; 2,550 RSUs which vest in one installment of 2,550 on 4/25/2015; 2,993 RSUs which vest in two annual installments of 1,474 and 1,519 on 4/27/2015 and 4/27/2016, respectively; 4,439 RSUs which vest in three installments of 1,464, 1,465 and 1,510 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; 7,488 RSUs which vest in one installment of 3,688 on 10/25/2015 and one installment of 3,800 on 10/25/2016; and 4,707 RSUs which vest in two equal installments of 1,553 on 1/31/2016 and 1/31/2017 and one installment of 1,601 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 500 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| October 25, 2014 Filed Oct 28, 2014 20:09 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,925 | $147.26 | $283,475.50 |
DisclosureSEC source: 0001127602-14-030380 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,393 Read SEC document |
| April 27, 2014 Filed Apr 29, 2014 21:54 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 28 | $111.41 | $3,119.48 |
DisclosureSEC source: 0001127602-14-015510 · form4.xml · nonDerivative · entry 4 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,091 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 22,081 RSUs which fully vest on 12/31/2014; 2,550 RSUs which vest in one installment of 2,550 on 4/25/2015; 2,993 RSUs which vest in two annual installments of 1,474 and 1,519 on 4/27/2015 and 4/27/2016, respectively; 4,439 RSUs which vest in three installments of 1,464, 1,465 and 1,510 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; 11,176 RSUs which vest in two equal installments of 3,688 each on 10/25/2014 and 10/25/2015 and one installment of 3,800 on 10/25/2016; and 4,707 RSUs which vest in two equal installments of 1,553 on 1/31/2016 and 1/31/2017 and one installment of 1,601 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 342 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 27, 2014 Filed Apr 29, 2014 21:54 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 734 | $111.41 | $81,774.94 |
DisclosureSEC source: 0001127602-14-015510 · form4.xml · nonDerivative · entry 3 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,119 Read SEC document |
| April 26, 2014 Filed Apr 29, 2014 21:54 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 723 | $111.41 | $80,549.43 |
DisclosureSEC source: 0001127602-14-015510 · form4.xml · nonDerivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,853 Read SEC document |
| April 25, 2014 Filed Apr 29, 2014 21:54 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,234 | $113.72 | $140,330.48 |
DisclosureSEC source: 0001127602-14-015510 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,576 Read SEC document |
| March 14, 2014 Filed Mar 18, 2014 20:31 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 9,411 | $123.96 | $1,166,587.56 |
DisclosureSEC source: 0001127602-14-012031 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,810 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,450 RSUs which fully vest on 4/26/2014; 22,081 RSUs which fully vest on 12/31/2014; 5,025 RSUs which vest in one installment of 2,475 on 4/25/2014 and one installment of 2,550 on 4/25/2015; 4,466 RSUs which vest in three installments of 1,473, 1,474 and 1,519 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 4,439 RSUs which vest in three installments of 1,464, 1,465 and 1,510 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; 11,176 RSUs which vest in two equal installments of 3,688 each on 10/25/2014 and 10/25/2015 and one installment of 3,800 on 10/25/2016; and 4,707 RSUs which vest in two equal installments of 1,553 on 1/31/2016 and 1/31/2017 and one installment of 1,601 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 396 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 05, 2014 Filed Mar 7, 2014 22:38 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 18,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-010756 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,096 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,450 RSUs which fully vest on 4/26/2014; 22,081 RSUs which fully vest on 12/31/2014; 5,025 RSUs which vest in one installment of 2,475 on 4/25/2014 and one installment of 2,550 on 4/25/2015; 4,466 RSUs which vest in three installments of 1,473, 1,474 and 1,519 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 4,439 RSUs which vest in three installments of 1,464, 1,465 and 1,510 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; 11,176 RSUs which vest in two equal installments of 3,688 each on 10/25/2014 and 10/25/2015 and one installment of 3,800 on 10/25/2016; and 4,707 RSUs which vest in two equal installments of 1,553 on 1/31/2016 and 1/31/2017 and one installment of 1,601 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 271 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 31, 2014 Filed Feb 4, 2014 23:05 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 4,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-004396 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,691 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 1,450 RSUs which fully vest on 4/26/2014; 22,081 RSUs which fully vest on 12/31/2014; 5,025 RSUs which vest in one installment of 2,475 on 4/25/2014 and one installment of 2,550 on 4/25/2015; 4,466 RSUs which vest in three installments of 1,473, 1,474 and 1,519 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 4,439 RSUs which vest in three installments of 1,464, 1,465 and 1,510 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; 11,176 RSUs which vest in two equal installments of 3,688 each on 10/25/2014 and 10/25/2015 and one installment of 3,800 on 10/25/2016; and 4,707 RSUs which vest in two equal installments of 1,553 on 1/31/2016 and 1/31/2017 and one installment of 1,601 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 271 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| October 25, 2013 Filed Oct 29, 2013 22:15 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 11,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-029949 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,900 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 10/25/2014, 10/25/2015 and 10/25/2016, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 1,450 RSUs which fully vest on 4/26/2014; 22,081 RSUs which fully vest on 12/31/2014; 5,025 RSUs which vest in one installment of 2,475 on 4/25/2014 and one installment of 2,550 on 4/25/2015; 4,466 RSUs which vest in three installments of 1,473, 1,474 and 1,519 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 4,439 RSUs which vest in three installments of 1,464, 1,465 and 1,510 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; and 11,176 which vest in two equal installments of 3,688 each on 10/25/2014 and 10/25/2015 and one installment of 3,800 on 10/25/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 187 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 29, 2013 Filed Apr 30, 2013 21:21 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-13-014777 · form4.xml · derivative · entry 8 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2016-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2013 Filed Apr 30, 2013 21:21 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,000 | $107.02 | $1,070,191.00 |
DisclosureSEC source: 0001127602-13-014777 · form4.xml · nonDerivative · entry 6 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,643 F2 · price: The price reported is an average price. The prices ranged from $106.8707 to $107.1316 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer. F3 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,450 RSUs which fully vest on 4/26/2014; 22,081 RSUs which fully vest on 12/31/2014; 5,025 RSUs which vest in one installment of 2,475 on 4/25/2014 and one installment of 2,550 on 4/25/2015; 4,466 RSUs which vest in three installments of 1,473, 1,474 and 1,519 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 4,439 RSUs which vest in three installments of 1,464, 1,465 and 1,510 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F4 · balance_after: These shares include 106 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 29, 2013 Filed Apr 30, 2013 21:21 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 10,000 | $50.44 | $504,400.00 |
DisclosureSEC source: 0001127602-13-014777 · form4.xml · nonDerivative · entry 5 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2013 Filed Apr 30, 2013 21:21 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 711 | $108.38 | $77,058.18 |
DisclosureSEC source: 0001127602-13-014777 · form4.xml · nonDerivative · entry 4 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,643 Read SEC document |
| April 26, 2013 Filed Apr 30, 2013 21:21 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $58.43 | $0.00 |
DisclosureSEC source: 0001127602-13-014777 · form4.xml · derivative · entry 7 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2020-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2013 Filed Apr 30, 2013 21:21 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 723 | $108.66 | $78,561.18 |
DisclosureSEC source: 0001127602-13-014777 · form4.xml · nonDerivative · entry 3 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,354 Read SEC document |
| April 26, 2013 Filed Apr 30, 2013 21:21 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,000 | $107.99 | $1,079,872.00 |
DisclosureSEC source: 0001127602-13-014777 · form4.xml · nonDerivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,077 F1 · price: The price reported is an average price. The prices ranged from $107.96 to $108.00 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer. Read SEC document |
| April 26, 2013 Filed Apr 30, 2013 21:21 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 10,000 | $58.43 | $584,300.00 |
DisclosureSEC source: 0001127602-13-014777 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2013 Filed Apr 26, 2013 21:33 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 8,662 | $0.00 Strike: $54.69 | $0.00 |
DisclosureSEC source: 0001127602-13-014615 · form4.xml · derivative · entry 6 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,588 Underlying: Common Stock · 8,662 shares Expires 2021-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2013 Filed Apr 26, 2013 21:33 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,234 | $104.93 | $129,483.62 |
DisclosureSEC source: 0001127602-13-014615 · form4.xml · nonDerivative · entry 5 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,077 F3 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 22,081 RSUs which fully vest on 12/31/2014; 5,025 RSUs which vest in one installment of 2,475 on 4/25/2014 and one installment of 2,550 on 4/25/2015; 4,466 RSUs which vest in three installments of 1,473, 1,474 and 1,519 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 4,439 RSUs which vest in three installments of 1,464, 1,465 and 1,510 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F4 · balance_after: These shares include 106 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 25, 2013 Filed Apr 26, 2013 21:33 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 8,662 | $107.95 | $935,029.12 |
DisclosureSEC source: 0001127602-13-014615 · form4.xml · nonDerivative · entry 4 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,311 F2 · price: The price reported is an average price. The prices ranged from $107.88 to $108.105 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer. Read SEC document |
| April 25, 2013 Filed Apr 26, 2013 21:33 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 8,662 | $54.69 | $473,724.78 |
DisclosureSEC source: 0001127602-13-014615 · form4.xml · nonDerivative · entry 3 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2013 Filed Apr 26, 2013 21:33 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-014615 · form4.xml · nonDerivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,311 Read SEC document |
| April 24, 2013 Filed Apr 26, 2013 21:33 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 6,924 | $105.95 | $733,565.26 |
DisclosureSEC source: 0001127602-13-014615 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,311 F1 · price: The price reported is an average price. The prices ranged from $105.90 to $106.00 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer. Read SEC document |
| March 15, 2013 Filed Mar 19, 2013 23:48 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 8,647 | $92.18 | $797,080.46 |
DisclosureSEC source: 0001127602-13-011476 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,235 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 22,081 RSUs which fully vest on 12/31/2014; 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015; 4,466 RSUs which vest in three installments of 1,473, 1,474 and 1,519 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 4,439 RSUs which vest in three installments of 1,464, 1,465 and 1,510 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 106 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 06, 2013 Filed Mar 8, 2013 23:37 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 16,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-010172 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,836 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 22,081 RSUs which fully vest on 12/31/2014; 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015; 4,466 RSUs which vest in three installments of 1,473, 1,474 and 1,519 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 4,439 RSUs which vest in three installments of 1,464, 1,465 and 1,510 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 60 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.